IN187686B - - Google Patents

Info

Publication number
IN187686B
IN187686B IN573MU2000A IN187686B IN 187686 B IN187686 B IN 187686B IN 573MU2000 A IN573MU2000 A IN 573MU2000A IN 187686 B IN187686 B IN 187686B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Pai Srikanth Annappa
Rivankar Sangeeta Hanurmesh
Kocharekar Shilpa Sudhakar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Priority to IN573MU2000 priority Critical patent/IN187686B/en
Priority to YU2703A priority patent/YU2703A/sh
Priority to US10/296,765 priority patent/US7138387B2/en
Priority to PL00359624A priority patent/PL359624A1/xx
Priority to IL15338700A priority patent/IL153387A0/xx
Priority to PT00991825T priority patent/PT1299095E/pt
Priority to CA2414064A priority patent/CA2414064C/en
Priority to CNB008198292A priority patent/CN1254237C/zh
Priority to DK00991825T priority patent/DK1299095T3/da
Priority to KR1020027017362A priority patent/KR100810066B1/ko
Priority to AU3597201A priority patent/AU3597201A/xx
Priority to HU0301646A priority patent/HUP0301646A3/hu
Priority to AU2001235972A priority patent/AU2001235972B2/en
Priority to DE60011149T priority patent/DE60011149T2/de
Priority to JP2002503273A priority patent/JP4907833B2/ja
Priority to EP00991825A priority patent/EP1299095B1/en
Priority to PCT/IN2000/000124 priority patent/WO2001097796A1/en
Priority to NZ523643A priority patent/NZ523643A/en
Priority to BR0017268-5A priority patent/BR0017268A/pt
Priority to APAP/P/2002/002674A priority patent/AP2002002674A0/en
Priority to EA200300047A priority patent/EA005589B1/ru
Priority to AT00991825T priority patent/ATE267592T1/de
Priority to ES00991825T priority patent/ES2222271T3/es
Priority to MXPA02012611A priority patent/MXPA02012611A/es
Publication of IN187686B publication Critical patent/IN187686B/en
Priority to NO20025999A priority patent/NO20025999D0/no
Priority to ZA200300336A priority patent/ZA200300336B/en
Priority to BG107463A priority patent/BG107463A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN573MU2000 2000-06-21 2000-06-21 IN187686B (enExample)

Priority Applications (27)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (enExample) 2000-06-21 2000-06-21
EA200300047A EA005589B1 (ru) 2000-06-21 2000-12-14 Прозрачное водное анестезирующее средство
DE60011149T DE60011149T2 (de) 2000-06-21 2000-12-14 Klare wässrige anästhesierende zusammensetzung
PL00359624A PL359624A1 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
IL15338700A IL153387A0 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
PT00991825T PT1299095E (pt) 2000-06-21 2000-12-14 Composicao anestesica aquosa limpida
CA2414064A CA2414064C (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
CNB008198292A CN1254237C (zh) 2000-06-21 2000-12-14 透明水性麻醉组合物
DK00991825T DK1299095T3 (da) 2000-06-21 2000-12-14 Klart vandigt anæstetisk præparat
KR1020027017362A KR100810066B1 (ko) 2000-06-21 2000-12-14 투명 수용성 마취제 조성물
AU3597201A AU3597201A (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
HU0301646A HUP0301646A3 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
EP00991825A EP1299095B1 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
YU2703A YU2703A (sh) 2000-06-21 2000-12-14 Bistar vodeni anestetski preparat
JP2002503273A JP4907833B2 (ja) 2000-06-21 2000-12-14 透明水性麻酔剤組成物
AU2001235972A AU2001235972B2 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
PCT/IN2000/000124 WO2001097796A1 (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
NZ523643A NZ523643A (en) 2000-06-21 2000-12-14 Clear aqueous anaesthetic composition
BR0017268-5A BR0017268A (pt) 2000-06-21 2000-12-14 Composição farmacêutica de propofol, aquosa, lìmpida, estável na esterilização em autoclave, apropriada para administração parenteral, e processo para a preparação de uma composição farmacêutica de propofol, aquosa, lìmpida, estável na esterilização em autoclave, apropriada para administração parenteral
APAP/P/2002/002674A AP2002002674A0 (en) 2000-06-21 2000-12-14 Clear Aqueous Anaesthetic composition.
US10/296,765 US7138387B2 (en) 2000-06-21 2000-12-14 Clear aqueous composition comprising propofol and hydroxypropyl-beta-cyclodextrin
AT00991825T ATE267592T1 (de) 2000-06-21 2000-12-14 Klare wässrige anästhesierende zusammensetzung
ES00991825T ES2222271T3 (es) 2000-06-21 2000-12-14 Composicion anestesica acuosa transparente.
MXPA02012611A MXPA02012611A (es) 2000-06-21 2000-12-14 Composicion anestesica, acuosa, clara.
NO20025999A NO20025999D0 (no) 2000-06-21 2002-12-13 Klart, vandig anestetisk preparat
ZA200300336A ZA200300336B (en) 2000-06-21 2003-01-13 Clear aqueous anaesthetic composition.
BG107463A BG107463A (en) 2000-06-21 2003-01-16 Clear aqueous anaesthetic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (enExample) 2000-06-21 2000-06-21

Publications (1)

Publication Number Publication Date
IN187686B true IN187686B (enExample) 2002-06-08

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
IN573MU2000 IN187686B (enExample) 2000-06-21 2000-06-21

Country Status (26)

Country Link
US (1) US7138387B2 (enExample)
EP (1) EP1299095B1 (enExample)
JP (1) JP4907833B2 (enExample)
KR (1) KR100810066B1 (enExample)
CN (1) CN1254237C (enExample)
AP (1) AP2002002674A0 (enExample)
AT (1) ATE267592T1 (enExample)
AU (2) AU2001235972B2 (enExample)
BG (1) BG107463A (enExample)
BR (1) BR0017268A (enExample)
CA (1) CA2414064C (enExample)
DE (1) DE60011149T2 (enExample)
DK (1) DK1299095T3 (enExample)
EA (1) EA005589B1 (enExample)
ES (1) ES2222271T3 (enExample)
HU (1) HUP0301646A3 (enExample)
IL (1) IL153387A0 (enExample)
IN (1) IN187686B (enExample)
MX (1) MXPA02012611A (enExample)
NO (1) NO20025999D0 (enExample)
NZ (1) NZ523643A (enExample)
PL (1) PL359624A1 (enExample)
PT (1) PT1299095E (enExample)
WO (1) WO2001097796A1 (enExample)
YU (1) YU2703A (enExample)
ZA (1) ZA200300336B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (enExample) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
CA2470500C (en) * 2001-12-28 2012-05-15 Guilford Pharmaceuticals, Inc. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
BR0307518A (pt) * 2002-02-01 2004-12-28 Shimoda Biotech Pty Ltd Composição farmacêutica
CN100438861C (zh) 2002-07-29 2008-12-03 变换药品公司 含水2,6-二异丙基苯酚药物组合物
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
SI1585548T1 (sl) * 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
US20090192230A1 (en) * 2004-01-14 2009-07-30 Koichi Takeda Propofol-containing fat emulsion preparation
WO2006030450A2 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
EP1928412B1 (en) * 2005-08-12 2015-09-16 Bharat Serums & Vaccines Ltd. Aqueous anaesthetic compositions comprising propofol
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
US8563221B2 (en) * 2008-03-11 2013-10-22 3M Innovative Properties Company Phototools having a protective layer
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
US9096712B2 (en) 2009-07-21 2015-08-04 3M Innovative Properties Company Curable compositions, method of coating a phototool, and coated phototool
WO2011034845A1 (en) 2009-09-16 2011-03-24 3M Innovative Properties Company Fluorinated coating and phototools made therewith
KR101781659B1 (ko) 2009-09-16 2017-09-25 쓰리엠 이노베이티브 프로퍼티즈 컴파니 플루오르화된 코팅 및 그로 제조된 포토툴
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
EP2484350B1 (de) * 2011-02-04 2016-04-20 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung, enthaltend einen Komplex eines Propofolsalzes mit einem Cyclodextrin
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
EP2785352B1 (en) * 2011-11-29 2020-03-11 Jurox Pty Ltd Stable injectable pharmaceutical compositions comprising 2-hydroxypropyl-beta-cyclodextrin and alfaxalone
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
IL275725B (en) 2012-08-21 2022-08-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
EP3407875A4 (en) * 2016-01-29 2019-09-04 Cuda Anesthetics, LLC AQUEOUS PHARMACEUTICAL FORMULATION WITH PROPOFOL
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
YU2703A (sh) 2006-03-03
WO2001097796A1 (en) 2001-12-27
EA200300047A1 (ru) 2003-06-26
PL359624A1 (en) 2004-08-23
MXPA02012611A (es) 2004-07-30
DE60011149D1 (de) 2004-07-01
EP1299095A1 (en) 2003-04-09
US20040014718A1 (en) 2004-01-22
NO20025999L (no) 2002-12-13
DE60011149T2 (de) 2005-07-07
BG107463A (en) 2003-11-28
NZ523643A (en) 2004-05-28
EP1299095B1 (en) 2004-05-26
AU3597201A (en) 2002-01-02
DK1299095T3 (da) 2004-10-11
CN1254237C (zh) 2006-05-03
HUP0301646A2 (hu) 2003-09-29
US7138387B2 (en) 2006-11-21
CN1454085A (zh) 2003-11-05
EA005589B1 (ru) 2005-04-28
ATE267592T1 (de) 2004-06-15
HUP0301646A3 (en) 2005-06-28
PT1299095E (pt) 2004-10-29
AP2002002674A0 (en) 2002-12-31
ES2222271T3 (es) 2005-02-01
ZA200300336B (en) 2004-04-08
JP4907833B2 (ja) 2012-04-04
IL153387A0 (en) 2003-07-06
JP2003535893A (ja) 2003-12-02
CA2414064A1 (en) 2001-12-27
NO20025999D0 (no) 2002-12-13
KR100810066B1 (ko) 2008-03-05
AU2001235972B2 (en) 2005-07-21
KR20030023875A (ko) 2003-03-20
CA2414064C (en) 2013-01-08
BR0017268A (pt) 2003-05-27

Similar Documents

Publication Publication Date Title
FR07C0070I2 (enExample)
JP2003511934A5 (enExample)
JP2003511580A5 (enExample)
JP2001194580A5 (enExample)
JP2001152806A5 (enExample)
JP2002538736A5 (enExample)
JP2001176879A5 (enExample)
JP2002191586A5 (enExample)
IN187686B (enExample)
JP2001102926A5 (enExample)
JP2001042806A5 (enExample)
JP2002181834A5 (enExample)
JP2002016751A5 (enExample)
JP2002544436A5 (enExample)
JP2002149662A5 (enExample)
JP2001127305A5 (enExample)
JP2002168772A5 (enExample)
JP2002091486A5 (enExample)
JP2003512585A5 (enExample)
JP2002007558A5 (enExample)
IN186285B (enExample)
JP2002144103A5 (enExample)
ECSMU000167U (enExample)
JP2002204380A5 (enExample)
IN191246B (enExample)